FDA Inspection
OneBlood, Inc.OneBlood, Inc. – FDA Inspection, Mar 21, 2023
Record Details
This FDA Inspection record concerns OneBlood, Inc., with an inspection on March 21, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · abd896a3-a5e7-41f0-9808-a26c20e95026
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1200346
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 606.60(a)Equipment observed, standardized, calibrated
- 21 CFR 606.60(a)Equipment observed, standardized, calibrated
Full citation text and observation details available on the Dashboard.
Other FDA inspections of OneBlood, Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| January 26, 2026 | NAI | Blood and Blood Products | |
| February 21, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 2, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 3, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 30, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for OneBlood, Inc.
- FDA Inspection 1304338 - 2026-01-26
- FDA Inspection 1080683 - 2019-02-21
- FDA Inspection 1012283 - 2017-02-02
- FDA Inspection 905875 - 2014-12-03
- FDA Inspection 817493 - 2013-01-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.